I'm not saying this isn't a risk, but the same risk surely applies equally to most or all other pharmaceutical companies and drugs. Unless I'm missing something, I don't think there's anything that makes Race and Bisantrene particularly vulnerable in comparison to everyone else in this regard.
I think the important thing is that they can't bootleg it legally, and Race have assured us that they can't because the Bisantrene intellectual property is well protected.
I'm not saying this isn't a risk, but the same risk surely...
-
- There are more pages in this discussion • 1,632 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
